The Role of Presepsin as a Biomarker of Sepsis in Children: A Systemic Review and Meta-Analysis

IF 0.5 Q4 PEDIATRICS Journal of Pediatric Intensive Care Pub Date : 2022-11-17 DOI:10.1055/s-0042-1758479
D. Khera, Nisha Toteja, Simranjeet Singh, Siyaram Didel, Kuldeep Singh, A. Chugh, Surjit Singh
{"title":"The Role of Presepsin as a Biomarker of Sepsis in Children: A Systemic Review and Meta-Analysis","authors":"D. Khera, Nisha Toteja, Simranjeet Singh, Siyaram Didel, Kuldeep Singh, A. Chugh, Surjit Singh","doi":"10.1055/s-0042-1758479","DOIUrl":null,"url":null,"abstract":"\n Objectives Biomarkers in sepsis are an arena of avid research as they can facilitate timely diagnosis and help reduce mortality. Presepsin is a promising candidate with good diagnostic performance reported in adult and neonatal studies. However, there is no clear consensus about its utility in the pediatric age group. This study aimed to synthesize scientific evidence regarding the diagnostic and prognostic performance of presepsin in pediatric sepsis.\n Data Sources A systematic literature search was conducted in MEDLINE/PubMed, Cochrane Central Register of Clinical Trials, Google Scholar, and Scopus to identify relevant studies reporting the diagnostic and prognostic accuracy of presepsin.\n Study Selection Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we retrieved all controlled trials and observational studies on presepsin as a biomarker in children aged <19 years with sepsis.\n Data Extraction Two authors independently performed study screening, data extraction, and quality assessment of the included studies.\n Data Synthesis Among the 267 citations identified, a total of nine relevant studies were included in the final analysis. The pooled diagnostic sensitivity and specificity of presepsin were 0.99 (95% confidence interval [CI]; 0.97–1.00) and 0.88 (95% CI; 0.83–0.92), respectively, with a diagnostic odds ratio (DOR) of 28.15 (95% CI; 0.74–1065.67) and area under the curve (AUC) in summary receiver operating curve of 0.89. Prognostic accuracy for presepsin had a sensitivity of 0.64 (95% CI; 0.35–1.0), specificity of 0.62 (95% CI; 0.44–0.87), and DOR of 3.3 (95% CI; 0.20–53.43). For procalcitonin, the pooled sensitivity for diagnostic accuracy was 0.97 (95% CI; 0.94–1.00), specificity was 0.76 (95% CI; 0.69–0.82), DOR was 10.53 (95% CI; 5.31–20.88), and AUC was 0.81.\n Conclusion Presepsin has good diagnostic accuracy with high sensitivity and specificity. Its prognostic accuracy in predicting mortality is low.","PeriodicalId":44426,"journal":{"name":"Journal of Pediatric Intensive Care","volume":null,"pages":null},"PeriodicalIF":0.5000,"publicationDate":"2022-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatric Intensive Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0042-1758479","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives Biomarkers in sepsis are an arena of avid research as they can facilitate timely diagnosis and help reduce mortality. Presepsin is a promising candidate with good diagnostic performance reported in adult and neonatal studies. However, there is no clear consensus about its utility in the pediatric age group. This study aimed to synthesize scientific evidence regarding the diagnostic and prognostic performance of presepsin in pediatric sepsis. Data Sources A systematic literature search was conducted in MEDLINE/PubMed, Cochrane Central Register of Clinical Trials, Google Scholar, and Scopus to identify relevant studies reporting the diagnostic and prognostic accuracy of presepsin. Study Selection Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we retrieved all controlled trials and observational studies on presepsin as a biomarker in children aged <19 years with sepsis. Data Extraction Two authors independently performed study screening, data extraction, and quality assessment of the included studies. Data Synthesis Among the 267 citations identified, a total of nine relevant studies were included in the final analysis. The pooled diagnostic sensitivity and specificity of presepsin were 0.99 (95% confidence interval [CI]; 0.97–1.00) and 0.88 (95% CI; 0.83–0.92), respectively, with a diagnostic odds ratio (DOR) of 28.15 (95% CI; 0.74–1065.67) and area under the curve (AUC) in summary receiver operating curve of 0.89. Prognostic accuracy for presepsin had a sensitivity of 0.64 (95% CI; 0.35–1.0), specificity of 0.62 (95% CI; 0.44–0.87), and DOR of 3.3 (95% CI; 0.20–53.43). For procalcitonin, the pooled sensitivity for diagnostic accuracy was 0.97 (95% CI; 0.94–1.00), specificity was 0.76 (95% CI; 0.69–0.82), DOR was 10.53 (95% CI; 5.31–20.88), and AUC was 0.81. Conclusion Presepsin has good diagnostic accuracy with high sensitivity and specificity. Its prognostic accuracy in predicting mortality is low.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Presepsin作为儿童脓毒症的生物标志物的作用:一项系统综述和荟萃分析
脓毒症的生物标志物是一个热门的研究领域,因为它们可以促进及时诊断并帮助降低死亡率。pressepsin是一种很有前途的候选药物,在成人和新生儿研究中具有良好的诊断性能。然而,对于其在儿童年龄组的效用,尚无明确的共识。本研究的目的是综合科学的证据,关于presepsin在儿童败血症中的诊断和预后表现。我们在MEDLINE/PubMed、Cochrane Central Register of Clinical Trials、Google Scholar和Scopus中进行了系统的文献检索,以确定相关研究报告了presepsin的诊断和预后准确性。研究选择使用系统评价和荟萃分析指南的首选报告项目,我们检索了所有的对照试验和观察性研究,这些研究将presepsin作为19岁以下脓毒症儿童的生物标志物。两位作者独立进行了纳入研究的研究筛选、数据提取和质量评估。在确定的267项引用中,共有9项相关研究被纳入最终分析。presepsin的诊断敏感性和特异性为0.99(95%可信区间[CI];0.97-1.00)和0.88 (95% CI;0.83-0.92),诊断优势比(DOR)为28.15 (95% CI;总体受试者工作曲线的曲线下面积(AUC)为0.89。presepsin的预后准确性敏感性为0.64 (95% CI;0.35-1.0),特异性0.62 (95% CI;0.44-0.87), DOR为3.3 (95% CI;0.20 - -53.43)。对于降钙素原,诊断准确性的综合敏感性为0.97 (95% CI;0.94-1.00),特异性为0.76 (95% CI;0.69-0.82), DOR为10.53 (95% CI;5.31-20.88), AUC为0.81。结论Presepsin诊断准确性好,敏感性和特异性高。其预测死亡率的准确性较低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
14.30%
发文量
60
期刊最新文献
Harms Associated with Tracheal Reintubation After Unplanned Extubation: A Retrospective Cohort Study Kindergarten Readiness Assessment Scores in Children who Received Early Life Mechanical Ventilation in the Pediatric Intensive Care Unit “It Would Be All-Consuming”: Community Parents' Perceptions of the Pediatric Intensive Care Unit Extracorporeal Membrane Oxygenation: Rescue Therapy in Pediatric Bupropion Cardiotoxicity Social Disadvantage and Inequity in Access to Pediatric Critical Care Services for Children Living Remote from a Children's Hospital
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1